3-113326453-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001164496.2(CFAP44):c.4508G>A(p.Gly1503Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00001 in 1,498,902 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 11/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001164496.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CFAP44 | NM_001164496.2 | c.4508G>A | p.Gly1503Glu | missense_variant | 28/35 | ENST00000393845.9 | |
LOC127898559 | NR_183046.1 | n.7144G>A | non_coding_transcript_exon_variant | 41/48 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CFAP44 | ENST00000393845.9 | c.4508G>A | p.Gly1503Glu | missense_variant | 28/35 | 5 | NM_001164496.2 | P2 | |
CFAP44 | ENST00000461734.1 | c.371G>A | p.Gly124Glu | missense_variant, NMD_transcript_variant | 2/10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152130Hom.: 0 Cov.: 32
GnomAD4 exome AF: 0.00000446 AC: 6AN: 1346772Hom.: 0 Cov.: 31 AF XY: 0.00000302 AC XY: 2AN XY: 662462
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000673 AC XY: 5AN XY: 74312
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.4508G>A (p.G1503E) alteration is located in exon 28 (coding exon 27) of the CFAP44 gene. This alteration results from a G to A substitution at nucleotide position 4508, causing the glycine (G) at amino acid position 1503 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at